3440-28-6 | 3-(phenylformamido)propanoic acid

Packsize	Purity	Availability	Price	Discounted Price
25mg	98%	in stock	$6.00	$4.00
100mg	98%	in stock	$8.00	$6.00
5g	98%	in stock	$10.00	$7.00
10g	98%	in stock	$16.00	$11.00
25g	98%	in stock	$31.00	$22.00
100g	98%	in stock	$115.00	$81.00
500g	98%	in stock	$383.00	$268.00

Description

• Catalog Number: AB71104
• Chemical Name: 3-(phenylformamido)propanoic acid
• CAS Number: 3440-28-6
• Molecular Formula: C10H11NO3
• Molecular Weight: 193.1992
• MDL Number: MFCD00037293
• SMILES: O=C(c1ccccc1)NCCC(=O)O

Computed Properties

• Complexity: 209
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 14
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 4
• XLogP3: 0.5

Literature

• Structural effects of N-aromatic acyl-amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon-specific prodrug with controlled conversion rate at the target site.

  Biopharmaceutics & drug disposition 20110901

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Organocatalytic asymmetric addition of alcohols and thiols to activated electrophiles: efficient dynamic kinetic resolution and desymmetrization protocols.

  The Journal of organic chemistry 20080815

• Pharmacokinetics of 3-[125I]iodo-alpha-methyl-L-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells.

  Nuclear medicine and biology 20071101

• Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.

  Toxicology 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Population pharmacokinetic analysis of panipenem/betamipron in patients with various degrees of renal function.

  Chemotherapy 20060101

• Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.

  Journal of pharmaceutical sciences 20050701

• Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20050201

• Reaction of Pseudomonas fluorescens kynureninase with beta-benzoyl-L-alanine: detection of a new reaction intermediate and a change in rate-determining step.

  Biochemistry 20040323

• Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.

  Journal of pharmacological sciences 20040201

• Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors.

  The Journal of pharmacology and experimental therapeutics 20020601

• Thermodynamic quantitative structure-activity relationship analysis for enzyme-ligand interactions in aqueous phosphate buffer and organic solvent.

  Bioorganic & medicinal chemistry 20010801

• Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters.

  European journal of pharmacology 20010511

• Thermodynamic aspects of hydrophobicity and biological QSAR.

  Journal of computer-aided molecular design 20010401

• Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex.

  Japanese journal of pharmacology 19940901